Cite
HARVARD Citation
Lim, E. et al. (n.d.). Emerging data and future directions for CDK4/6 inhibitor treatment of patients with hormone receptor positive HER2‐non‐amplified metastatic breast cancer. Asia-Pacific journal of clinical oncology. pp. 12-21. [Online].